Bovine Mastitis Market Expansion Supported by Technological Advancements

Bovine Mastitis Market Expansion Supported by Technological Advancements, updated 6/2/25, 7:03 AM

categoryOther
visibility1

In 2019, the global bovine mastitis market was valued at USD 1.23 billion and is expected to grow to USD 1.84 billion by 2027, reflecting a compound annual growth rate (CAGR) of 5.2% over the forecast period. North America led the market in 2019, accounting for a dominant share of 32.52%.

Tag Cloud


https://www.fortunebusinessinsights.com/bovine-mastitis-market-103482

Bovine Mastitis Market Outlook: Emerging
Treatment and Prevention Trends
The bovine mastitis market is experiencing significant growth, driven by rising disease prevalence, increased
dairy production, and advancements in diagnostic and treatment methods. This article delves into the key
aspects shaping the market landscape.
In 2019, the global bovine mastitis market was valued at USD 1.23 billion and is expected to grow to USD
1.84 billion by 2027, reflecting a compound annual growth rate (C AGR) of 5.2% over the forecast period.
North America led the market in 2019, accounting for a dominant share of 32.52%.
Top Companies in the Market
 Zoetis (New Jersey, U.S.)
 Merck & Co., Inc. (MSD Animal Health) (New Jersey, U.S.)
 Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany)
 Bayer AG (Leverkusen, Germany)
 Elanco (Indiana, U.S.)
 Ceva (Libourne, France)
 West Way Health (Galway, Ireland)
 Others
Key Industry Development
In April 2021, Boehringer Ingelheim expanded its dairy mastitis portfolio by introducing the blue Ubroseal
internal teat sealant. This product aims to prevent new intramammary infections during the dry period,
enhancing udder health and milk quality.
Market Drivers & Restraints
Drivers:

Increasing prevalence of bovine mastitis, leading to economic losses in the dairy industry.
 Growing demand for dairy products, necessitating improved animal health management.
 Advancements in diagnostic tools and treatment options, including non-antibiotic therapies.
Restraints:
 Rising concerns over antibiotic resistance, prompting regulatory restrictions on antibiotic use.
 High costs associated with advanced diagnostic equipment and alternative treatments.
Market Report Coverage
The market report encompasses a comprehensive analysis of the bovine mastitis market, including
segmentation by type, product, route of administration, therapy, and region. It provides insights into market
size, growth trends, competitive landscape, and future outlook.

https://www.fortunebusinessinsights.com/bovine-mastitis-market-103482

Market Competitive Landscape
The bovine mastitis market is moderately competitive, with key players focusing on product innovation,
strategic collaborations, and expansion into emerging markets. Companies are investing in research and
development to introduce effective and sustainable treatment options.
Market Segments
By Type:
 Clinical Mastitis: Dominates the market due to visible symptoms and immediate economic impact.
 Sub-Clinical Mastitis: Expected to grow at a faster rate, driven by advancements in diagnostic
technologies.
By Product:
 Antibiotics
 Vaccines
 Non-Antibiotic Therapies
 Diagnostics
Explore the full research report with detailed insights and
TOC:https://www.fortunebusinessinsights.com/bovine-mastitis-market-103482
By Route of Administration:

Intra-Mammary
 Systemic
By Therapy:

Lactating Period
 Dry Period
Market Regional Insights
North America: Holds a significant market share, attributed to the adoption of intramammary infusion
products and the presence of leading market players.
Europe: Expected to witness substantial growth due to collaborations among key players and the launch of
innovative mastitis treatments.
Asia-Pacific: Anticipated to exhibit the fastest growth, driven by a large cattle population, increasing
incidence of mastitis, and government initiatives promoting animal health.
Future Market Scope
The bovine mastitis market is poised for continued growth, with a focus on sustainable and effective
treatment options. The integration of advanced diagnostic tools, such as rapid on-farm detection devices,
and the development of non-antibiotic therapies are expected to shape the future of the market.
Additionally, increasing awareness among farmers and regulatory support will further drive market
expansion.
About Us:
Fortune Business Insights provides expert corporate analysis and accurate data, enabling businesses of all
sizes to make timely decisions. We offer customized solutions tailored to each client’s needs, helping them
address unique challenges. Our goal is to empower clients with holistic market intelligence and offer
granular insights into the market they operate in.
Our reports are a blend of quantitative and qualitative analysis, aimed at helping businesses achieve
sustainable growth. Our experienced analysts and consultants use leading research methodologies to
provide comprehensive market assessments enriched with relevant data.
At Fortune Business Insights, we aim to highlight growth opportunities for our clients, offering insights and
recommendations that help them navigate technological and market changes. Our consulting services are
designed to help companies uncover hidden opportunities and address competitive challenges.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA: +1 833 909 2966 (Toll-Free),
United Kingdom: +44 808 502 0280 (Toll-Free),
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com